Hypoxia and the anticoagulants dalteparin and acetylsalicylic acid affect human placental amino acid transport. 2014

Marc-Jens Kleppa, and Sarah-Vanessa Erlenwein, and Natallia Darashchonak, and Constantin S von Kaisenberg, and Frauke von Versen-Höynck
Department of Obstetrics and Gynecology, Hannover Medical School, Hannover, Germany.

BACKGROUND Anticoagulants, e.g. low-molecular weight heparins (LMWHs) and acetylsalicylic acid (ASA) are prescribed to women at risk for pregnancy complications that are associated with impaired placentation and placental hypoxia. Beyond their role as anticoagulants these compounds exhibit direct effects on trophoblast but their impact on placental function is unknown. The amino acid transport systems A and L, which preferably transfer essential amino acids, are well-described models to study placental nutrient transport. We aimed to examine the effect of hypoxia, LMWHs and ASA on the activity of the placental amino acid transport systems A and L and associated signalling mechanisms. METHODS The uptake of C14-MeAIB (system A) or H3-leucin (system L) was investigated after incubation of primary villous fragments isolated from term placentas. Villous tissue was incubated at 2% O2 (hypoxia), 8% O2 and standard culture conditions (21% O2) or at 2% O2 and 21% O2 with dalteparin or ASA. Activation of the JAK/STAT or mTOR signalling pathways was determined by Western analysis of total and phosphorylated STAT3 or Raptor. RESULTS Hypoxia decreased system A mediated MeAIB uptake and increased system L mediated leucine uptake compared to standard culture conditions (21% O2). This was accompanied by an impairment of STAT3 and a stimulation of Raptor signalling. System L activity increased at 8% O2. Dalteparin treatment reduced system A and system L activity under normoxic conditions and ASA (1 mM) decreased system A and L transporter activity under normoxic and hypoxic conditions. CONCLUSIONS Our data underline the dependency of placental function on oxygen supply. LMWHs and ASA are not able to reverse the effects of hypoxia on placental amino acid transport. These findings and the uncovering of the signalling mechanisms in more detail will help to understand the impact of LMWHs and ASA on placental function and fetal growth.

UI MeSH Term Description Entries
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D010920 Placenta A highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion (CHORIONIC VILLI) derived from TROPHOBLASTS and a maternal portion (DECIDUA) derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones (PLACENTAL HORMONES). Placentoma, Normal,Placentome,Placentas,Placentomes
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D002250 Carbon Radioisotopes Unstable isotopes of carbon that decay or disintegrate emitting radiation. C atoms with atomic weights 10, 11, and 14-16 are radioactive carbon isotopes. Radioisotopes, Carbon
D002824 Chorionic Villi Threadlike vascular projections of the chorion. Chorionic villi may be free or embedded within the DECIDUA forming the site for exchange of substances between fetal and maternal blood (PLACENTA). Placental Villi,Labyrinth of the Placenta,Labyrinthine Placenta,Placental Labyrinth Layer,Chorionic Villus,Labyrinth Layer, Placental,Placental Labyrinth Layers,Placental Villus,Villi, Chorionic,Villi, Placental,Villus, Chorionic,Villus, Placental
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000076223 Regulatory-Associated Protein of mTOR An adaptor protein component of the MECHANISTIC TARGET OF RAPAMYCIN COMPLEX 1 that forms stoichiometric complexes with TOR KINASES, which it negatively regulates. It functions as a positive regulator of RIBOSOMAL PROTEIN S6 KINASES. RAPTOR Protein,RPTOR Protein,Regulatory Associated Protein of mTOR,mTOR Regulatory-Associated Protein
D000860 Hypoxia Sub-optimal OXYGEN levels in the ambient air of living organisms. Anoxia,Oxygen Deficiency,Anoxemia,Deficiency, Oxygen,Hypoxemia,Deficiencies, Oxygen,Oxygen Deficiencies
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect

Related Publications

Marc-Jens Kleppa, and Sarah-Vanessa Erlenwein, and Natallia Darashchonak, and Constantin S von Kaisenberg, and Frauke von Versen-Höynck
December 1974, American journal of obstetrics and gynecology,
Marc-Jens Kleppa, and Sarah-Vanessa Erlenwein, and Natallia Darashchonak, and Constantin S von Kaisenberg, and Frauke von Versen-Höynck
June 1995, The American journal of physiology,
Marc-Jens Kleppa, and Sarah-Vanessa Erlenwein, and Natallia Darashchonak, and Constantin S von Kaisenberg, and Frauke von Versen-Höynck
September 1985, Nihon Sanka Fujinka Gakkai zasshi,
Marc-Jens Kleppa, and Sarah-Vanessa Erlenwein, and Natallia Darashchonak, and Constantin S von Kaisenberg, and Frauke von Versen-Höynck
January 2020, Journal of applied physiology (Bethesda, Md. : 1985),
Marc-Jens Kleppa, and Sarah-Vanessa Erlenwein, and Natallia Darashchonak, and Constantin S von Kaisenberg, and Frauke von Versen-Höynck
January 2006, Methods in molecular medicine,
Marc-Jens Kleppa, and Sarah-Vanessa Erlenwein, and Natallia Darashchonak, and Constantin S von Kaisenberg, and Frauke von Versen-Höynck
April 2008, Journal of neuroendocrinology,
Marc-Jens Kleppa, and Sarah-Vanessa Erlenwein, and Natallia Darashchonak, and Constantin S von Kaisenberg, and Frauke von Versen-Höynck
September 1986, Federation proceedings,
Marc-Jens Kleppa, and Sarah-Vanessa Erlenwein, and Natallia Darashchonak, and Constantin S von Kaisenberg, and Frauke von Versen-Höynck
January 2006, Methods in molecular medicine,
Marc-Jens Kleppa, and Sarah-Vanessa Erlenwein, and Natallia Darashchonak, and Constantin S von Kaisenberg, and Frauke von Versen-Höynck
April 1992, The American journal of physiology,
Marc-Jens Kleppa, and Sarah-Vanessa Erlenwein, and Natallia Darashchonak, and Constantin S von Kaisenberg, and Frauke von Versen-Höynck
October 1987, Nihon Sanka Fujinka Gakkai zasshi,
Copied contents to your clipboard!